These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 26699506)

  • 1. Hepatitis C virus utilizes VLDLR as a novel entry pathway.
    Ujino S; Nishitsuji H; Hishiki T; Sugiyama K; Takaku H; Shimotohno K
    Proc Natl Acad Sci U S A; 2016 Jan; 113(1):188-93. PubMed ID: 26699506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mice Expressing Minimally Humanized CD81 and Occludin Genes Support Hepatitis C Virus Uptake In Vivo.
    Ding Q; von Schaewen M; Hrebikova G; Heller B; Sandmann L; Plaas M; Ploss A
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of human factors CD81, claudin-1, scavenger receptor, and occludin in mouse hepatocytes does not confer susceptibility to HCV entry.
    Hikosaka K; Noritake H; Kimura W; Sultana N; Sharkar MT; Tagawa Y; Uezato T; Kobayashi Y; Wakita T; Miura N
    Biomed Res; 2011 Apr; 32(2):143-50. PubMed ID: 21551950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CLEC4M-positive and CD81-negative Huh7 cells are not susceptible to JFH-1 HCVcc infection but mediate transinfection.
    Ishibashi M; Morita N; Nomura-Kawaguchi C; Shimizu Y; Wakita T; Esumi M
    Arch Virol; 2014 Nov; 159(11):2949-55. PubMed ID: 24965233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tandem overexpression of five human factors renders murine hepatocytes susceptible to hepatitis C virus.
    Lv L; Kang Q; Yu X; Gao B; Hu T; Ma P; Zhang Y; Yan F; Xiao J; Deng J; Zhou X; Xu J
    Acta Virol; 2015 Mar; 59(1):20-6. PubMed ID: 25790047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD81 Receptor Regions outside the Large Extracellular Loop Determine Hepatitis C Virus Entry into Hepatoma Cells.
    Banse P; Moeller R; Bruening J; Lasswitz L; Kahl S; Khan AG; Marcotrigiano J; Pietschmann T; Gerold G
    Viruses; 2018 Apr; 10(4):. PubMed ID: 29677132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanding the Host Range of Hepatitis C Virus through Viral Adaptation.
    von Schaewen M; Dorner M; Hueging K; Foquet L; Gerges S; Hrebikova G; Heller B; Bitzegeio J; Doerrbecker J; Horwitz JA; Gerold G; Suerbaum S; Rice CM; Meuleman P; Pietschmann T; Ploss A
    mBio; 2016 Nov; 7(6):. PubMed ID: 27834208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In silico directed mutagenesis identifies the CD81/claudin-1 hepatitis C virus receptor interface.
    Davis C; Harris HJ; Hu K; Drummer HE; McKeating JA; Mullins JG; Balfe P
    Cell Microbiol; 2012 Dec; 14(12):1892-903. PubMed ID: 22897233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of candidate virus receptors in human T lymphocytes prone or resistant to infection with patient-derived hepatitis C virus.
    Sarhan MA; Chen AY; Michalak TI
    PLoS One; 2013; 8(4):e62159. PubMed ID: 23626783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor.
    Bartosch B; Vitelli A; Granier C; Goujon C; Dubuisson J; Pascale S; Scarselli E; Cortese R; Nicosia A; Cosset FL
    J Biol Chem; 2003 Oct; 278(43):41624-30. PubMed ID: 12913001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus cell entry: role of lipoproteins and cellular receptors.
    Burlone ME; Budkowska A
    J Gen Virol; 2009 May; 90(Pt 5):1055-1070. PubMed ID: 19264629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigallocatechin gallate (EGCG) and miR-548m reduce HCV entry through repression of CD81 receptor in HCV cell models.
    Mekky RY; El-Ekiaby N; El Sobky SA; Elemam NM; Youness RA; El-Sayed M; Hamza MT; Esmat G; Abdelaziz AI
    Arch Virol; 2019 Jun; 164(6):1587-1595. PubMed ID: 30949812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alirocumab, a Therapeutic Human Antibody to PCSK9, Does Not Affect CD81 Levels or Hepatitis C Virus Entry and Replication into Hepatocytes.
    Ramanathan A; Gusarova V; Stahl N; Gurnett-Bander A; Kyratsous CA
    PLoS One; 2016; 11(4):e0154498. PubMed ID: 27115873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein Receptors Redundantly Participate in Entry of Hepatitis C Virus.
    Yamamoto S; Fukuhara T; Ono C; Uemura K; Kawachi Y; Shiokawa M; Mori H; Wada M; Shima R; Okamoto T; Hiraga N; Suzuki R; Chayama K; Wakita T; Matsuura Y
    PLoS Pathog; 2016 May; 12(5):e1005610. PubMed ID: 27152966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infection with hepatitis C virus depends on TACSTD2, a regulator of claudin-1 and occludin highly downregulated in hepatocellular carcinoma.
    Sekhar V; Pollicino T; Diaz G; Engle RE; Alayli F; Melis M; Kabat J; Tice A; Pomerenke A; Altan-Bonnet N; Zamboni F; Lusso P; Emerson SU; Farci P
    PLoS Pathog; 2018 Mar; 14(3):e1006916. PubMed ID: 29538454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus infection and tight junction proteins: The ties that bind.
    Mailly L; Baumert TF
    Biochim Biophys Acta Biomembr; 2020 Jul; 1862(7):183296. PubMed ID: 32268133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus entry: potential receptors and their biological functions.
    Cocquerel L; Voisset C; Dubuisson J
    J Gen Virol; 2006 May; 87(Pt 5):1075-1084. PubMed ID: 16603507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of hypervariable region 1 for the interplay of hepatitis C virus with entry factors and lipoproteins.
    Bankwitz D; Vieyres G; Hueging K; Bitzegeio J; Doepke M; Chhatwal P; Haid S; Catanese MT; Zeisel MB; Nicosia A; Baumert TF; Kaderali L; Pietschmann T
    J Virol; 2014 Nov; 88(21):12644-55. PubMed ID: 25142595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of palmitoylation of CD81 on its association with tetraspanin-enriched microdomains and mediating hepatitis C virus cell entry.
    Zhu YZ; Luo Y; Cao MM; Liu Y; Liu XQ; Wang W; Wu DG; Guan M; Xu QQ; Ren H; Zhao P; Qi ZT
    Virology; 2012 Aug; 429(2):112-23. PubMed ID: 22560863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus depends on E-cadherin as an entry factor and regulates its expression in epithelial-to-mesenchymal transition.
    Li Q; Sodroski C; Lowey B; Schweitzer CJ; Cha H; Zhang F; Liang TJ
    Proc Natl Acad Sci U S A; 2016 Jul; 113(27):7620-5. PubMed ID: 27298373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.